Cheiron
Los Altos, United States
◆ Total Raised
$8M
◆ Stage
seed
◆ Location
Los Altos, United States
◆ Founded
2024
◆ Team size
11-50
◆ Links
◆ About Cheiron
AI-native operating system for drug development programs that models the live state of drug programs as a single connected system.
◆ What sets it apart
Cheiron models an entire drug program as a single connected system, using a proprietary life sciences knowledge graph and workflow-native AI agents to produce traceable, cross-domain outputs.
◆ Sectors
◆ Business
ModelSaaS
Customerbiopharma teams, including biotech founders, translational research teams, clinical development, regulatory affairs, medical affairs, and program leadership
◆ Notable
- Raised an $8 million seed round led by Menlo Ventures
- Built a life sciences knowledge graph spanning major public biopharma data sources
- Launched AI agents for life sciences workflows across research, clinical, regulatory, medical, and commercial functions
◆ Backing funds on Raise
- Anthology Fundseed
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Cheiron do?
AI-native operating system for drug development programs that models the live state of drug programs as a single connected system.
Where is Cheiron based?
Cheiron is based in Los Altos, United States, founded in 2024.
How much has Cheiron raised?
Cheiron has raised $8M in tracked funding and is currently at the seed stage.
Who has invested in Cheiron?
Investors in Cheiron include Menlo Ventures, Moderna co-founder Robert Langer, Freda Lewis-Hall, Josh Meier, Laxman Narasimhan and John Giannandrea.